[1] Wang C,Horby PW,Hayden FG,et al.A novel coronavirus outbreak of global health concern[J]. Lancet,2020,395(10223):470-473.
[2] World Health Organization.Weekly epidemiological update on COVID-19-21 December2022[EB/OL].(2022-12-21)[2023-04-30].https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports.
[3] Alkandari D,Herbert JA,Alkhalaf MA,et al.SARS-CoV-2 vaccines:Fast track versus efficacy[J].Lancet Microbe,2021,2(3):e89-e90.
[4] 杨惠洁,孙誉芳,王军志,等.新型冠状病毒肺炎疫苗有效性和安全性概述[J].中国新药杂志,2022,31(21):2082-2089.
[5] 冯基花,张剑锋.新型冠状病毒疫苗潜在不良反应的研究进展[J].广西科学,2021,28(2):103-112.
[6] 国家卫生健康委员会办公厅,国家药品监督管理局综合司.全国疑似预防接种异常反应监测方案(2022年版)[EB/OL].(2022-06-10)[2023-05-25].http://wjw.jiangsu.gov.cn/art/2022/12/15/art_7312_10707582.html.
[7] 中国疾病预防控制中心,国家药品不良反应监测中心.全国新冠病毒疫苗预防接种不良反应监测信息解读[EB/OL].(2021-05-28)[2023-05-25].http://www.chinacdc.cn/jkzt/ymyjz/ymyjjz_6758/202105/t20210528_230908.html.
[8] 国家卫生健康委疾控局,中国疾病预防控制中心.新冠疫苗疑似预防接种异常反应(AEFI)监测处置要点[EB/OL].(2021-04)[2023-05-25].https://www.med66.com/upload/resources/file/2021/04/06/254441.pdf.
[9] 刘文敏,杨丹丹,王卫平,等.上海市浦东新区18岁及以上人群接种新型冠状病毒灭活疫苗疑似预防接种异常反应监测结果分析[J].现代预防医学,2022,49(15):2851-2855.
[10] 黄芳芳,孙亚兵,赵金凤.2017—2019年阳泉市疑似预防接种异常反应监测[J].预防医学论坛,2021,27(8):636-639.
[11] Greinacher A,Thiele T,Warkentin TE,et al.Thrombotic thrombocytopenia after ChAdOx1 nCov-19 Vaccination[J].N Engl J Med,2021,384(22):2092-2101.
[12] Scully M,Singh D,Lown R,et al.Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination[J].N Engl J Med,2021,384(23):2202-2211.
[13] Schultz NH,Sørvoll IH,Michelsen AE,et al.Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination[J].N Engl J Med,2021,384(22):2124-2130.
[14] 杨明磊,鲍宇玲,谭松巍,等.新型冠状病毒疫苗meta分析[J].中国科技论文在线精品论文,2022,9(15):332-340.
[15] Al Khames Aga QA,Alkhaffaf WH,Hatem TH,et al.Safety of COVID-19 vaccines[J].J Med Virol,2021,93(12):6588-6594.
[16] 刘文敏,文京海,杨丹丹,等.上海市浦东新区重组新型冠状病毒疫苗(5型腺病毒载体)接种情况及安全性分析[J].中国公共卫生,2023,6(39):777-781.
[17] Creech CB,Anderson E,Berthaud V,et al.Evaluation of mRNA-1273 covid-19 vaccine in children 6 to 11 years of age[J].N Engl J Med,2022,386(21):2011-2023.
[18] 朱瑶,韦意娜,孙畅,等.新型冠状病毒肺炎疫苗研究进展[J].预防医学,2021,33(2):143-148.
[19] 余娜,刘玉娜,柏晓玲,等.贵阳市≥60岁老年人新冠病毒疫苗加强免疫后AEFI主动监测分析[J].中国公共卫生,2022,9(38):1113-1117.
[20] Fischinger S,Boudreau CM,Butler AL,et al.Sex differences in vaccine-induced humoral immunity[J].Semin Immunopathol,2019,41(2):239-249.
[21] Fathi A,Addo MM,Dahlke C.Sex differences in immunity:Implications for the development of novel vaccines against emerging pathogens[J].Front Immunol,2020,11:601170.
[22] 高田,吕攀,王巍,等.60岁以上老年人新冠疫苗接种不良反应及对基础疾病的影响[J].中国临床研究,2023,36(7):1077-1082.
[23] 梁亚琼,徐鹭,陈敏.2016—2021年南京市疑似预防接种异常反应监测[J].华南预防医学,2022,48(11):1400-1403. |
